MuznyCASchwebkeJRNyirjesyP, et al.Efficacy and safety of single oral dosing of secnidazole for trichomoniasis in women: results of a phase 3, randomized, double-blind, placebo-controlled, delayed-treatment study. Clin Infect Dis2021: ciab242. Epub ahead of print. DOI: 10.1093/cid/ciab242.
2.
SanmukhaniJShahVBaxiS, et al.Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report. Br J Clin Pharmacol2010; 69(6): 703–704. DOI: 10.1111/j.1365-2125.2010.03651.x.
3.
KanwarAJSharmaRRajagopalanM, et al.Fixed drug eruption due to tinidazole with cross sensitivity to metronidazole. Dermatology1990; 180: 277.
4.
ThamiGPKanwarAJ. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole. Dermatology1998; 196: 368.
5.
KuroharaMLKwongFKLebherzTB, et al.Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol1991; 88: 279–280.
6.
HelmsDJMosureDJSecorWE, et al.Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol2008; 198(4): 370.e1–370.e7.
